I realize that the decision to shelve the Jacobs Hope Program for the moment is not popular with some. However I believe that Novogen needs to take tiny baby steps with the JHP until we find suitable partners with deep pockets. Sorting out the IP is one step. I think that the first in human trials with Cantrixil - which comes from the same SBP family will also be a helpful step.
NRT Price at posting:
11.0¢ Sentiment: Hold Disclosure: Held
